Nordic DX

Main Menu

  • Home
  • Medical devices
  • Medical products
  • Medicine importation
  • Medicine quality

Nordic DX

Header Banner

Nordic DX

  • Home
  • Medical devices
  • Medical products
  • Medicine importation
  • Medicine quality
Medical devices
Home›Medical devices›TII plans to enter electronics and energy products, medical devices

TII plans to enter electronics and energy products, medical devices

By Joseph M. Juarez
May 13, 2022
0
0

The Murugappa Group’s engineering company, Tube Investments of India Ltd. (TII), plans to enter new business segments such as medical devices and instruments, electronic products and components, and energy-related products.

The company’s board of directors on Thursday gave the go-ahead, subject to shareholder approval, for the insertion of three new sub-clauses in the memorandum of association (MoA) to allow the company to s engage in the activities, according to a statement.

Last year, the company announced its entry into the electric mobility segment, where it seeks to focus on electric three-wheelers. It also acquired Hyderabad-based electric tractor start-up Cellestial E-Mobility in January this year.

The board also approved the termination of the company’s Global Depository Receipts (GDR) program, given the small number of unlisted GDRs outstanding (constituting approximately 0.001% of the share capital). The Bank of New York Mellon is the custodian of the GDRs.

The board also approved new long-term borrowings of up to ₹500 crore to meet funding needs in FY23.

The board of directors has given the go-ahead for the conversion of the remaining 8,52,33,645 stock warrants into an equal number of shares of CG Power and Industrial Solutions Ltd. by paying the balance of 75% of the subscriptions no later than May 26, 2022.

TII said profit after tax rose to ₹136 crore for the quarter ended March 31 from ₹129 crore a year earlier. Earnings before exceptional items amounted to ₹173 crore (₹162 crore). Operating revenue increased to ₹1,629 crore from ₹1,396 crore.

“The results for the quarter show a stable performance even in the wake of challenges related to supply constraints, lower domestic demand, higher fuel and commodity prices fueling inflation, some of which was also due to the war in Ukraine, but exports have consistently generated good growth in the tube and industrial chain sector,” said MAM Arunachalam, Chairman of Tube Investments of India.

For the full financial year FY22, net profit increased to ₹475 crore from ₹273 crore in the previous year, which was impacted by the second wave of COVID. Operating revenue increased to ₹5,987 crore from ₹4,026 crore.

The board also recommended a final dividend of ₹1.50 per share for FY22.

Categories

  • Medical devices
  • Medical products
  • Medicine importation

Recent Posts

  • Common Causes of Faulty Medical Devices
  • Khairy: Drug shortage will be resolved by next month | Daily Express Online
  • Utah Medical Products (NASDAQ:UTMD) Stock Price Breaks Below 200-Day Moving Average of $90.62
  • Respiratory Care Medical Devices Market Size, Scope and Forecast
  • Steerable Medical Devices Market Research Report | Top Industry Players Deserve Medical Systems, Integer Holdings Corporation, DEAM, DePuy Synthes – Forecast to 2029

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • March 2021
  • February 2021
  • January 2021
  • November 2020
  • October 2020
  • May 2020
  • April 2019
  • December 2018
  • Privacy Policy
  • Terms and Conditions